Media

Pulmonx to Report First Quarter 2022 Financial Results on May 3, 2022

BONESUPPORT Holding AB publishes Annual Report 2021

Priothera Receives First Regulatory Approvals to Start a Global Pivotal Study with Mocravimod in Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Spruce Biosciences Appoints Libbie Mansell, Ph.D., M.B.A., R.A.C., as Chief Regulatory and Quality Officer

Carisma Therapeutics to Present Engineered Cell Therapy Data at The American Association for Cancer Research Annual Meeting

Vicore Pharma publishes the Annual Report for 2021

Nordic Nanovector ASA Announces Proposed Board Changes – Former Algeta CEO Thomas Ramdahl nominated to Join Board of Directors

Aro Biotherapeutics to Highlight Therapeutic Potential of Centyrin Oligonucleotide Conjugates at Upcoming Industry Conferences

Michael Wolff Jensen resigns from the Vicore board of directors and is replaced by Jacob Gunterberg as chairman of the board up until the annual general meeting in May 2022